Abstract: A targeted drug delivery device comprises a brush for use in delivery of one or more therapeutic agents during surgical procedures, including but not limited to, heart, chest, abdominal, brain, limb, vascular, eye, organ transplantation surgery or cancer surgical treatment. The therapeutic agent is selected from the group consisting of genetically engineered vectors or cells, proteins, stem cells, small molecule pharmaceuticals, drugs or biologics. Methods of treating diseases comprising delivering at least one therapeutic agent to a patient's organs or tissues using any one of the targeted drug delivery devices are disclosed.
Type:
Application
Filed:
August 27, 2020
Publication date:
September 15, 2022
Applicant:
Rithim Biologics, Inc.
Inventors:
John Kevin Donahue, Ronald Lee Anderson
Abstract: The present invention relates to a targeted cardiac therapy device that can precisely deliver therapeutic compounds to desired locations on, around or within the heart of a patient, and methods of treating conduction system disease, sinus node dysfunction, atrial fibrillation, myocardial infarction, and heart failure, using the described devices to deliver genetically engineered vectors or cells, proteins, stem cells, small molecule pharmaceuticals and biologics.
Type:
Grant
Filed:
January 11, 2018
Date of Patent:
June 28, 2022
Assignee:
RITHIM BIOLOGICS, INC.
Inventors:
John Kevin Donahue, Ronald Lee Anderson
Abstract: The present invention relates to a targeted cardiac therapy device that can precisely deliver therapeutic compounds to desired locations on, around or within the heart of a patient, and methods of treating conduction system disease, sinus node dysfunction, atrial fibrillation, myocardial infarction, heart failure, and muscular diseases with cardiac involvement, using the described devices to deliver genetically engineered vectors or cells, proteins, stem cells, small molecule pharmaceuticals and biologics.
Type:
Application
Filed:
March 7, 2022
Publication date:
June 16, 2022
Applicant:
Rithim Biologics, Inc.
Inventors:
John Kevin Donahue, Ronald Lee Anderson
Abstract: The present invention relates to a targeted cardiac therapy device that can precisely deliver therapeutic compounds to desired locations on, around or within the heart of a patient, and methods of treating conduction system disease, sinus node dysfunction, atrial fibrillation, myocardial infarction, and heart failure, using the described devices to deliver genetically engineered vectors or cells, proteins, stem cells, small molecule pharmaceuticals and biologics.
Type:
Application
Filed:
January 11, 2018
Publication date:
November 21, 2019
Applicant:
RITHIM BIOLOGICS, INC.
Inventors:
John Kevin DONAHUE, Ronald Lee ANDERSON